Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings

Shares (Q2 2026)
513,840
Value
$2.71M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ACRS by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026513,840$2.71M<0.1%+2,379+0.5%AddedHolders
Q1 2026511,461$1.91M<0.1%+240,611+88.8%AddedHolders
Q4 2025270,850$814.6K<0.1%+106,606+64.9%AddedHolders
Q3 2025164,244$312.2K<0.1%−43,029−20.8%ReducedHolders
Q2 2025207,273$294.6K<0.1%−147,576−41.6%ReducedHolders
Q1 2025354,849$543.3K<0.1%+115,254+48.1%AddedHolders
Q4 2024239,595$594.2K<0.1%+162,785+211.9%AddedHolders
Q3 202476,810$88.3K<0.1%+51+0.1%AddedHolders
Q2 202476,759$84.4K<0.1%−12,302−13.8%ReducedHolders
Q1 202489,061$110.4K<0.1%−98,492−52.5%ReducedHolders
Q4 2023187,553$196.9K<0.1%−74,180−28.3%ReducedHolders
Q3 2023261,733$1.79M<0.1%+161,276+160.5%AddedHolders
Q2 2023100,457$1.04M<0.1%−37,466−27.2%ReducedHolders
Q1 2023137,923$1.12M<0.1%+89,906+187.2%AddedHolders
Q4 202248,017$756.0K<0.1%00.0%UnchangedHolders
Q3 202248,017$756.0K<0.1%+48,017NewHolders
Q4 20210$00.0%−18,640−100.0%Sold outHolders
Q3 202118,640$336.0K<0.1%00.0%UnchangedHolders
Q2 202118,640$327.0K<0.1%00.0%UnchangedHolders
Q1 202118,640$470.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.